Startseite Crystal structure of (3E,5E)-3,5-bis(4-fluorobenzylidene)-1-((4-trifluoromethyl)benzenesulfonyl)piperidin-4-one, C26H18F5NO3S
Artikel Open Access

Crystal structure of (3E,5E)-3,5-bis(4-fluorobenzylidene)-1-((4-trifluoromethyl)benzenesulfonyl)piperidin-4-one, C26H18F5NO3S

  • Zhong-Fei Gao , Lei Wang ORCID logo , Gui-Ge Hou ORCID logo und Xiao-Fan Zhang ORCID logo EMAIL logo
Veröffentlicht/Copyright: 2. September 2021
Artikel downloaden (PDF)
Veröffentlichen auch Sie bei De Gruyter Brill
Manuskript einreichen Informationen für Autor*innen
Zeitschrift für Kristallographie - New Crystal Structures
Aus der Zeitschrift Zeitschrift für Kristallographie - New Crystal Structures Band 236 Heft 6

Abstract

C26H18F5NO3S, triclinic, P 1 ‾ (no. 2), a = 7.8831(4) Å, b = 11.9591(7) Å, c = 13.3258(7) Å, α = 69.072(5)°, β = 88.556(4)°, γ = 73.730(5)°, V = 1122.48(11) Å3, Z = 2, R gt (F) = 0.0507, wR ref (F2) = 0.1216, T = 100.0(1) K.

CCDC no.: 2103981

Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Yellow block
Size: 0.14 × 0.12 × 0.10 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.22 mm−1
Diffractometer, scan mode: SuperNova,
θmax, completeness: 29.6°, >99%
N(hkl)measured, N(hkl)unique, Rint: 12,356, 5294, 0.032
Criterion for Iobs, N(hkl)gt: Iobs > 2σ(Iobs), 4144
N(param)refined: 325
Programs: CrysAlisPRO [1], Shelx [2, 3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z Uiso*/Ueq
C1 0.6245 (3) 0.49568 (19) 0.32766 (16) 0.0204 (4)
H1A 0.672869 0.547280 0.266911 0.025*
H1B 0.714554 0.456990 0.387854 0.025*
C2 0.4638 (3) 0.5783 (2) 0.35755 (16) 0.0219 (4)
C3 0.3133 (3) 0.52704 (19) 0.39938 (15) 0.0208 (4)
C4 0.3200 (2) 0.40041 (19) 0.40027 (15) 0.0193 (4)
C5 0.4951 (3) 0.32090 (19) 0.38201 (16) 0.0210 (4)
H5A 0.570449 0.279806 0.448999 0.025*
H5B 0.474953 0.256714 0.359422 0.025*
C6 0.4407 (3) 0.6995 (2) 0.34183 (16) 0.0234 (4)
H6 0.331586 0.740863 0.358513 0.028*
C7 0.5623 (3) 0.7758 (2) 0.30232 (17) 0.0244 (5)
C8 0.4897 (3) 0.9051 (2) 0.24935 (18) 0.0299 (5)
H8 0.367195 0.939410 0.241474 0.036*
C9 0.5950 (3) 0.9826 (2) 0.20869 (18) 0.0324 (5)
H9 0.545673 1.068166 0.172639 0.039*
C10 0.7745 (3) 0.9294 (2) 0.22313 (17) 0.0282 (5)
C11 0.8548 (3) 0.8037 (2) 0.27762 (16) 0.0240 (4)
H11 0.977686 0.771826 0.287092 0.029*
C12 0.7481 (3) 0.7261 (2) 0.31796 (16) 0.0228 (4)
H12 0.799282 0.640971 0.355439 0.027*
C13 0.1691 (3) 0.36798 (19) 0.40819 (15) 0.0201 (4)
H13 0.066478 0.425800 0.414602 0.024*
C14 0.1518 (2) 0.24925 (19) 0.40759 (16) 0.0204 (4)
C15 0.2630 (3) 0.13494 (19) 0.47520 (17) 0.0247 (5)
H15 0.348292 0.133267 0.523102 0.030*
C16 0.2480 (3) 0.0242 (2) 0.47189 (19) 0.0296 (5)
H16 0.321826 −0.052124 0.517421 0.036*
C17 0.1222 (3) 0.0288 (2) 0.40016 (19) 0.0289 (5)
C18 0.0073 (3) 0.1393 (2) 0.33258 (18) 0.0278 (5)
H18 −0.077816 0.139791 0.285263 0.033*
C19 0.0231 (3) 0.2497 (2) 0.33755 (17) 0.0236 (4)
H19 −0.053694 0.325551 0.293321 0.028*
C20 0.3392 (3) 0.53275 (19) 0.12335 (15) 0.0194 (4)
C21 0.3311 (3) 0.6585 (2) 0.08351 (16) 0.0245 (5)
H21 0.433541 0.682656 0.083388 0.029*
C22 0.1691 (3) 0.7477 (2) 0.04396 (17) 0.0265 (5)
H22 0.161566 0.832345 0.017175 0.032*
C23 0.0178 (3) 0.7096 (2) 0.04463 (16) 0.0229 (4)
C24 0.0264 (3) 0.5838 (2) 0.08493 (16) 0.0236 (4)
H24 −0.075989 0.559595 0.085210 0.028*
C25 0.1881 (3) 0.4946 (2) 0.12467 (16) 0.0219 (4)
H25 0.195541 0.409979 0.151978 0.026*
C26 −0.1567 (3) 0.8044 (2) −0.00493 (17) 0.0285 (5)
F1 0.88070 (19) 1.00437 (13) 0.18209 (11) 0.0390 (3)
F2 0.10867 (18) −0.08073 (12) 0.39666 (12) 0.0396 (4)
F3 −0.16273 (17) 0.91979 (13) −0.01286 (12) 0.0398 (3)
F4 −0.19243 (18) 0.81126 (15) −0.10532 (11) 0.0454 (4)
F5 −0.29304 (16) 0.77733 (14) 0.05012 (11) 0.0399 (4)
N1 0.5844 (2) 0.39745 (15) 0.29951 (13) 0.0180 (3)
O1 0.18551 (18) 0.58662 (14) 0.43178 (12) 0.0250 (3)
O2 0.67987 (18) 0.47214 (14) 0.11741 (11) 0.0249 (3)
O3 0.53295 (19) 0.30282 (14) 0.17191 (12) 0.0261 (3)
S1 0.54701 (6) 0.41882 (5) 0.17298 (4) 0.01909 (13)

Source of material

The synthesis of 3,5-bis(4-fluorobenzylidene)piperidin-4-one was carried out by the Claisen–Schmidt condensation reaction [4]. 4-Piperidone hydrochloride (0.68 g, 5 mmol) and 4-fluorobenzaldehyde (1.24 g, 10 mmol) were added into glacial acetic acid (10 mL). Under a dry HCl flow, the mixture was stirred to obtain a clear solution. Then, the reaction continued to be stirred at room temperature for 24 h. The endpoint of which was determined by thin-layer chromatography (TLC). After the reaction was complete, the above mixture was poured to 100 mL water and adjusted to neutral pH by an aqueous Na2CO3 solution. The obtained yellow solids were filtered and washed twice by water. The intermediate 3,5-bis(4-fluorobenzylidene)piperidin-4-one was obtained by the recrystallization of methanol solution. The curcumin analogue and 4-trifluoromethylbenzene-sulfonyl chloride (1.22 g, 5 mmol) were dissolved in dichloromethane (100 mL). The solution was stirred under the catalysis of organic pyridine (two drop) and monitored by TLC. After 24 h, the precipitate was collected and dried under vacuum conditions. The resulting product was recrystallized from dichloromethane/petroleum ether (1:1, v/v). Single crystals of the title compound were prepared by slow evaporation of dichloromethane/methanol solutions at room temperature.

Experimental details

The H atoms were positioned geometrically and treated as riding on their parent atoms, with d (C–H) = 0.97 Å (methylene) and Uiso(H) = 1.2Ueq(C); d(C–H) = 0.93 Å (aromatic) and Uiso(H) = 1.2Ueq(C).

Comment

Curcumin, acknowledged as 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, has attracted extensive attentions because of their potential applications in the aspect of anti-inflammatory, anti-proliferative and antiangiogenic therapies [5], [6], [7]. As an α,β-unsaturated polyphenol compound, it can be considered as one kind of chemopreventive and anticancer agent [8, 9]. Just because of the presence of a diketone group, curcumin becomes unstable at physiological pH. Rapid metabolism and deficient absorption affect its pharmacokinetics and hinder its clinical application [10]. In order to overcome the defect, it is important to modify its structure with mono ketone instead of the β-diketone group. Liu’s group synthesized novel curcumin analogues by the deletion of a methylene and the β-diketone moiety groups. Among these compounds, 5,7-dimethoxy-3-(3-(2-((1E,4E)-3-oxo-5-(pyridin-2-yl)penta-1,4-dien-1-yl)phenoxy)propoxy)-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one could induce gastric cancer cells apoptosis by inhibiting the TrxR activity [11]. Li’s group reported that curcumin analogues based on a cyclohexanone moiety possess anti-inflammatory properties [12]. It was found that heterocyclic compounds often exhibit a wide range of biological activities such as antimicrobial, antitumor and antimalarial properties [13]. A piperidone ring was introduced to curcumin analogues and a set of 3,5-bis(arylidene)-4-piperidones were designed [14, 15]. Previous results indicated that fluorine-containing substituents in the aromatic rings usually imparted some distinctive properties to medicines including enhanced binding interactions, metabolic stability, and selective reactivity of compounds [16]. Additionally, it was reported that the phenylsulfonyl moiety in 3,5-bis(arylidene)-4-piperidones could significantly improve the bioactivity of anti-inflammatory [17]. As a part of our continuing study on anti-neuroinflammatory agents, one new curcumin analogue containing the piperidone ring, a fluorine atom and phenylsulfonyl moiety was synthesized by the Claisen–Schmidt condensation reaction and N-benzenesulfonylation reaction.

Single-crystal structure analysis shows that the asymmetric unit consists of a 3,5-bis(arylidene)-4-piperidinone molecule (cf. Figure). All bond lengths and bond angles were found to be consistent with the values reported in the literature [18], [19], [20], [21]. Both 4-fluorobenzylidene moieties are symmetrically arranged on the both sides of the central piperidone scaffold. In the title molecule, the torsion angles of C3–C2–C6–C7 and C3–C4–C13–C14 bonds are 179.84(19)° and 178.45(17)°, respectively. It means that the title molecule is in the E stereochemistry of the exocyclic olefinic double bonds. The piperidone ring displays a half-chair conformation with the N1 atom deviating by 0.594(2) Å from the least-squares plane through the ring. The title compound is obviously not planar with the dihedral angle between the fluorophenyl and piperidone rings being 31.97(6)° and 63.87(6)°, respectively. The dihedral angle between fluorophenyl rings is 48.21(7)°. The phenylsulfonyl moiety adopts a pseudo-axial conformation with respect to the piperidone ring, meaning that the molecule as a whole forms a “organic click” in the direction of the carbonyl group. No classic hydrogen bonds were found. Neighbouring molecules are linked via weak C–H⋯F hydrogen bonds to a two-dimensional sheet in the ab plane. Molecules containing as a group the α,β-unsaturated ketone and peripheric heteroatoms (such as O and F) may have anticancer, anti-bacterial and antifungal activities [22].

Corresponding author: Xiao-Fan Zhang, School of Pharmacy, The Key Laboratory of Prescription Effect and Clinical Evaluation of State Administration of Traditional Chinese Medicine of China, Binzhou Medical University, Yantai, 264003, P. R. China, E-mail:

Funding source: Project of Shandong Province Higher Educational Science and Technology Program

Award Identifier / Grant number: J18KA092

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by the Project of the Shandong Province Higher Educational Science and Technology Program (No. J18KA092).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Rigaku, O. D. CrysAlisPRO; Rigaku Oxford Diffraction Ltd: Yarnton, Oxfordshire, England, 2017.Suche in Google Scholar

2. Sheldrick, G. M. A short history of Shelx. Acta Crystallogr. 2008, A64, 112–122; https://doi.org/10.1107/s0108767307043930.Suche in Google Scholar PubMed

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar PubMed PubMed Central

4. Osman, H., Idris, N. H., Kamarulzaman, E. E., Wahab, H. A., Hassan, M. Z. 3,5-Bis(arylidene)-4-piperidones as potential dengue protease inhibitors. Acta Pharm. Sin. B 2017, 7, 479–484; https://doi.org/10.1016/j.apsb.2017.04.009.Suche in Google Scholar PubMed PubMed Central

5. Schmitt, F., Subramaniam, D., Anant, S., Padhye, S., Begemann, G., Schobert, R., Biersack, B. Halogenated bis(methoxybenzylidene)-4-piperidone curcuminoids with improved anticancer activity. ChemMedChem 2018, 13, 1115–1123; https://doi.org/10.1002/cmdc.201800135.Suche in Google Scholar PubMed

6. Sun, J., Zhang, S., Yu, C., Hou, G., Zhang, X., Li, K., Zhao, F. Design, synthesis and bioevaluation of novel N-substituted-3,5-bis(arylidene)-4-piperidone derivatives as cytotoxic and antitumor agents with fluorescent properties. Chem. Biol. Drug Des. 2014, 83, 392–400; https://doi.org/10.1111/cbdd.12254.Suche in Google Scholar PubMed

7. Ocasio-Malave, C., Donate, M. J., Sanchez, M. M., Sosa-Rivera, J. M., Mooney, J. W., Pereles-De Leon, T. A., Carballeira, N. M., Zayas, B., Velez-Gerena, C. E., Martinez-Ferrer, M., Sanabria-Rios, D. J. Synthesis of novel 4-boc-piperidone chalcones and evaluation of their cytotoxic activity against highly-metastatic cancer cells. Bioorg. Med. Chem. Lett 2020, 30, 126760; https://doi.org/10.1016/j.bmcl.2019.126760.Suche in Google Scholar PubMed PubMed Central

8. Kalai, T., Kuppusamy, M. L., Balog, M., Selvendiran, K., Rivera, B. K., Kuppusamy, P., Hideg, K. Synthesis of N-substituted 3,5-bis(arylidene)-4-piperidones with high antitumor and antioxidant activity. J. Med. Chem. 2011, 54, 5414–5421; https://doi.org/10.1021/jm200353f.Suche in Google Scholar PubMed

9. Pricci, M., Girardi, B., Giorgio, F., Losurdo, G., Ierardi, E., Di Leo, A. Curcumin and colorectal cancer: from basic to clinical evidences. Int. J. Mol. Sci. 2020, 21, 2364; https://doi.org/10.3390/ijms21072364.Suche in Google Scholar PubMed PubMed Central

10. Kotha, R. R., Luthria, D. L. Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules 2019, 24, 2930; https://doi.org/10.3390/molecules24162930.Suche in Google Scholar PubMed PubMed Central

11. Wang, J. Q., Wang, X., Wang, Y., Tang, W. J., Shi, J. B., Liu, X. H. Novel curcumin analogue hybrids: synthesis and anticancer activity. Eur. J. Med. Chem. 2018, 156, 493–509; https://doi.org/10.1016/j.ejmech.2018.07.013.Suche in Google Scholar PubMed

12. Liang, G., Yang, S., Zhou, H., Shao, L., Huang, K., Xiao, J., Huang, Z., Li, X. Synthesis, crystal structure and anti-inflammatory properties of curcumin analogues. Eur. J. Med. Chem. 2009, 44, 915–919; https://doi.org/10.1016/j.ejmech.2008.01.031.Suche in Google Scholar PubMed

13. Damayanti, P. N., Ritmaleni, S. E. P. Synthesis and antibacterial activity of 4-piperidone curcumin analogues against gram-positive and gram-negative bacteria. Res. J. Pharm. Technol. 2020, 13, 4765–4769; https://doi.org/10.5958/0974-360x.2020.00838.0.Suche in Google Scholar

14. Liu, G.-Y., Jia, C.-C., Han, P.-R., Yang, J. 3,5-Bis(2-fluorobenzy-lidene)-4-piperidone induce reactive oxygen species-mediated apoptosis in A549 cells. Med. Chem. Res. 2017, 27, 128–136; https://doi.org/10.1007/s00044-017-2056-x.Suche in Google Scholar

15. Zhang, L., Chen, Q., Hou, G., Zhao, W., Hou, Y. Hydroxyl-substituted double Schiff-base condensed 4-piperidone/cyclohexanones as potential anticancer agents with biological evaluation. J. Enzym. Inhib. Med. Chem. 2019, 34, 264–271; https://doi.org/10.1080/14756366.2018.1501042.Suche in Google Scholar PubMed PubMed Central

16. Hagmann, W. K. The many roles for fluorine in medicinal chemistry. J. Med. Chem. 2008, 51, 4359–4369; https://doi.org/10.1021/jm800219f.Suche in Google Scholar PubMed

17. Li, N., Xin, W. Y., Yao, B. R., Cong, W., Wang, C. H., Hou, G. G. N-Phenylsulfonyl-3,5-bis(arylidene)-4-piperidone derivatives as activation NF-κB inhibitors in hepatic carcinoma cell lines. Eur. J. Med. Chem. 2018, 155, 531–544; https://doi.org/10.1016/j.ejmech.2018.06.027.Suche in Google Scholar PubMed

18. Zhang, J. J., Chen, D. X., Lv, L. Y., Qi, C. H., Xu, W. C., Hou, G. G. Crystal structure and anti-inflammatory activity of (3E, 5E)-3,5-bis(2-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)piperidin-4-one, C25H18F3NO3S. Z. Kristallogr. N. Cryst. Struct. 2020, 235, 1051–1053; https://doi.org/10.1515/ncrs-2020-0165.Suche in Google Scholar

19. Yan, W. B., Liu, Y. J., Hou, G. G., Cong, W., Meng, Q. G. Crystal structure and anti-inflammatory activity of (3E,5E)-3,5-bis(4-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)piperidin-4-one-dichloromethane (1/1), C26H20Cl2F3NO3S. Z. Kristallogr. N. Cryst. Struct. 2020, 235, 947–949; https://doi.org/10.1515/ncrs-2020-0116.Suche in Google Scholar

20. Wang, A. Q., Gao, R. N., Luan, Q. H., Wang, Z. P., Li, X. M., Hou, G. G. Crystal structure and anti-inflammatory activity of (3E,5E)-3-(2-fluorobenzylidene)-1-((4-acetamidophenyl)sulfonyl)-5-(pyridin-3-ylmethylene)piperidin-4-one-methanol-hydrate (2/1/1), C53H50F2N6O10S2. Z. Kristallogr. N. Cryst. Struct. 2020, 235, 381–384; https://doi.org/10.1515/ncrs-2019-0686.Suche in Google Scholar

21. Sun, Y., Liu, Y. K., Li, J. D., Meng, Q. G., Hou, G. G. Crystal structure and anti-inflammatory activity of (3E, 5E)-3-(2-fluorobenzy-lidene)-1-((4-fluorophenyl)sulfonyl)-5-(pyridin-3-ylmethylene)piperidin-4-one, C24H18F2N2O3S. Z. Kristallogr. N. Cryst. Struct. 2020, 235, 377–379; https://doi.org/10.1515/ncrs-2019-0683.Suche in Google Scholar

22. Goslinski, T., Piskorz, J. Fluorinated porphyrinoids and their biomedical applications. J. Photochem. Photobiol. C 2011, 12, 304–321; https://doi.org/10.1016/j.jphotochemrev.2011.09.005.Suche in Google Scholar
Received: 2021-07-24
Accepted: 2021-08-18
Published Online: 2021-09-02
Published in Print: 2021-12-20

© 2021 Zhong-Fei Gao et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Redetermination of the crystal structure of 3-bromonitrobenzene at 200 K, C6H4BrNO2 – temperature effects on cell constants
  4. Crystal structure of (E)-ethyl 2-((4-oxo-4H-chromen-3-yl)methyleneaminooxy)acetate, C14H13NO5
  5. Crystal structure of (8R,10R,14R, Z)-2-((3–Fluoropyridin-4-yl) methylene)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((R)-2,6, 6-trimethyltetrahydro-2H-pyran-2-yl) hexadecahydro-3H-cyclopenta[a] phenanthren-3-one, C36H52FNO3
  6. Crystal structure of [6,6′-((1E,1′E)-(propane-1,3- diylbis(azaneylylidene))bis(methaneylylidene)) bis(3-chlorophenol)-κ4N,N′,O,O′] copper(II), C17H14Cl2CuN2O2
  7. The crystal structure of 6-amino-2-carboxypyridin-1-ium bromide, C6H7BrN2O2
  8. Redetermination of the crystal structure of bis[N,N′-ethylenebis(acetylacetoniminato)nickel(II)] sodium perchlorate, C24H36ClN4NaNi2O8
  9. The crystal structure of 3-methyl-2,6-dinitrophenol, C7H6N2O5
  10. The crystal structure of 5-chloro-2-(quinolin-8-yl)isoindoline-1,3-dione, C17H9ClN2O2
  11. Crystal structure of trans-tetraaqua-bis{2-carboxy-4-((5-carboxypyridin-3-yl)oxy)benzoato-κ1 N}cobalt(II) dihydrate C28H28O20N2Co
  12. Crystal structure of 3-allyl-4-(2-bromoethyl)-5-(4-methoxyphenyl)-2-(p-tolyl)furan, C23H23BrO2
  13. The crystal structure of 6,6′-(((2-(dimethylamino)ethyl)azanediyl)bis(methylene))bis(benzo[d][1,3]dioxol-5-ol ato-κ4N,N′,O,O′)-(pyridine-2,6-dicarboxylato-N,O,O′)-titanium(IV)-dichloromethane(1/1), C27H25N3O10Ti
  14. Crystal structure of (((1E,1′E)-1,2-phenylenebis(methaneylylidene))bis(hydrazin-1-yl-2-ylidene))bis(aminomethaniminium) dinitrate C10H16N10O6
  15. Crystal structure of catena-poly[triaqua-(μ 2-1,3-di(1H-imidazol-1-yl)propane-κ 2 N:N′)-(4,4′-(1H-1,2,4-triazole-3,5-diyl)dibenzoato-κ 1 O)nickel(II)]N,N′-dimethylformamide (1/1), C28H35N8O8Ni
  16. The crystal structure of 3,3′-[1,4-phenylenebis(methylene)]bis(1-ethenyl-1H-imidazol-3-ium) dichloride – dichloromethane – water (1/1/1), C19H24Cl4N4O1
  17. Crystal structure of 1,1′-(methane-1,1-diyl)bis(3-propyl-1H-imidazol-3-ium) bis(hexafluoridophosphate), C13H22F12N4P2
  18. Crystal structure of dichlorido-bis(4-chlorophenyl-κC 1)tin(IV), C12H8Cl4Sn
  19. Synthesis and crystal structure of 4-acetylpyrene, C18H12O
  20. Crystal structure of 2,2′-(butane-1,4-diylbis(azanylylidene))bis(methanylylidene))bis(4-methoxyphenol), C20H24N2O4
  21. The crystal structure of (E)-2-(((5-((triphenylstannyl)thio)-1,3,4-thiadiazol-2-yl)imino)methyl)phenol, C27H21N3OS2Sn
  22. Crystal structure of diaqua-bis(μ2-6-phenylpyridine-2-carboxylate-κ3N,O:O)-bis(6-phenylpyridine-2-carboxylato-κ2N,O)lead(II) – N,N-dimethylformamide – water (1/2/4), C54H58N6O16Pb2
  23. Crystal structure of methyl 4-acetoxy-3-methoxybenzoate, C11H12O5
  24. Crystal structure of 2,2′-(propane-1,3-dilylbis(azaneylylidene))bis(methanylylidene)bis(4-methylphenol), C19H22N2O2
  25. Crystal structure of dichlorido-bis(4-methylphenyl-κC1)tin(IV), C14H14Cl2Sn
  26. Crystal structure of methyl (E)-3-(4-acetoxyphenyl)acrylate, C12H12O4
  27. The crystal structure of bis(benzoato-κ2 O,O′)-(2,9-dimethyl-1,10-phenanthroline-κ2 N,N′)-copper(II), C28H22CuN2O4
  28. Crystal structure of (8R,10R,14R,Z)-12-hydroxy-2-((6-methoxypyridin-2-yl)methylene)-4,4,8,10,14-pentamethyl-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)hexadecahydro-3H-cyclopenta[a]phenanthren-3-one–water (2/1), C37H56NO4.5
  29. Crystal structure of dimethyl-bis(4-bromophenyl-κC1)tin(IV), C14H14Br2Sn
  30. The crystal structure of the cocrystal di-μ2-chlorido-octamethyl-di-μ3-oxido-bis(2,3,4,5-tetrafluorobenzoato-κ2 O,O′)tetratin(IV) ─ octamethyl-di-μ3-oxido-bis(μ2-2,3,4,5-tetrafluorobenzoato-κ2 O:O′)-bis(μ2-2,3,4,5-tetrafluorobenzoato-κ2 O:O;O′)tetratin(IV) C58H54Cl2F24O16Sn8
  31. Crystal structure of 3-iodo-N 2-(2-methyl-1-(methylsulfonyl)propan-2-yl)-N 1-(2-methyl-4-(perfluoropropan-2-yl)phenyl)phthalamide, C23H22F7I1N2O4S1
  32. Crystal structure of 1-(2-(4-bromophenyl)-2,3-dihydro-1H-benzo[e]indol-1-yl)-naphthalen-2-ol – dichloromethane – dimethyl sulfoxide (1/1/1), C28H18BrNO·CH2Cl2·C2H6SO
  33. Crystal structure of [meso-5,7,7,12,14,14,-hexamethyl-1,4,8,11-tetraazacyclotetradecane]nickel(II) diperchlorate – dimethylsulphoxide (1/2), C20H48Cl2N4NiO10S2
  34. Crystal structure of 1,1′-(1,3-phenylenebis(methylene))bis(pyridin-1-ium) bis(1,2-dicyanoethene-1,2-dithiolato-κ2 S:S) palladium(II), C26H18N6PdS4
  35. The crystal structure of bis(6-phenylpyridine-2-carboxylato-κ2 N,O)copper(II), C24H16N2O4Cu
  36. Crystal structure of dichlorido-bis(4-chlorophenyl-κC)-bis(triphenylarsine oxide-κO)tin(IV), C48H38As2Cl4O2Sn
  37. Crystal structure of (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane-κ 8 N 2, O 6) potassium cyclopentadienide, [K([2.2.2]crypt)]Cp, C23H41KN2O6
  38. The crystal structure of bis(2-oxidopyridin-1-ium-3-carboxylato-κ2O,O′)-(phenantroline-κ2N,N′)manganese(II) - methanol (1/3), C27H28N4O9Mn
  39. Crystal structure of 4-(dimethylamino)pyridinium dibromido-tris(4-chlorophenyl-κC)stannate(IV), C25H23Br2Cl3N2Sn
  40. Crystal structure of (3E,5E)-1-(4-cyanobenzenesulfonyl)-3,5-bis(3-fluorobenzylidene)piperidin-4-one-dichloromethane (1/1), C27H20Cl2F2N2O3S
  41. Crystal structure of (3E,5E)-3,5-bis(4-fluorobenzylidene)-1-((4-trifluoromethyl)benzenesulfonyl)piperidin-4-one, C26H18F5NO3S
  42. Crystal structure of chlorido-(4-methyl-2-((phenylimino)methyl)phenolato-κ2 N,O)-(pyridine-κ1 N)platinum(II), C19H17ClN2OPt
  43. Crystal structure of (4-methylbenzyl)(triphenyl)phosphonium chloride dihydrate, C26H28ClO2P
  44. The crystal structure of poly[μ2-chlorido-(μ2-1,2-bis(4-pyridyl)ethane-κ2N:N′silver(I)], C12H12AgClN2
  45. Crystal structure of poly[(μ4-benzene-1,2,4,5-tetracarboxylato)-bis(μ2-adipohydrazide)dicadmium], C11H15N4O6Cd
  46. The crystal structure of (E)-N′-(butan-2-ylidene)isonicotinohydrazide 0.5 hydrate C10H13N3O·0.5H2O
  47. The crystal structure of bis(6-phenylpyridine-2-carboxylate-κ2 N,O)-(2,2′-bipyridine-κ2 N,N′)zinc(II) monohydrate, C34H26N4O5Zn
  48. The crystal structure of (1R *,2S *)-1,2-bis(2-fluorophenyl)-3,8-dimethoxyacenaphthene-1,2-diol, C26H20F2O4
  49. Crystal structure of catena-poly[(μ2-1-((2-ethyl-4-methyl-1H-imidazol-1-yl)methyl)-1H-benzotriazole-κ2N:N′)-(nitrato-κ2O,O′)silver (I)], C13H15Ag1N6O3
  50. The crystal structure of [(phenantroline-κ2 N,N′)-bis(6-phenylpyridine-2-carboxylate-κ2 N,O)cobalt(II)]monohydrate, C36H26N4O5Co
  51. Crystal structure of (1E)-N′-[(1E)-1-(4-chlorophenyl)ethylidene]-2-[1-(4-chlorophenyl)ethylidene]hydrazine-1-carbohydrazonamide, C 17 H 17 Cl 2 N 5
  52. The crystal structure of (E)-2-((tert-butylimino)methyl)-4-chlorophenol, C11H14ClNO
  53. Crystal structure of all-cis-2,4,6-trihydroxycyclohexane- 1,3,5-triaminium chloride sulfate, C6H18ClN3O7S
  54. Crystal structure of dichlorido-bis(dimethyl sulfoxide-κO)bis(4-methylphenyl-κC 1)tin(IV), C18H26Cl2O2S2Sn
  55. Crystal structure of dichlorido-bis(4-chlorophenyl-κC 1)(2,2′-bipyridyl-κ 2 N,N′)tin(IV), C22H16Cl4N2Sn
  56. Redetermination of the crystal structure of (E)-5-bromo-2-hydroxybenzaldehyde oxime, C 7 H 6 BrNO 2
  57. The crystal structure of (E)-amino(2-(4-methylbenzylidene)hydrazineyl)methaniminium 4-methylbenzoate, C9H13N4 + C8H7O2 −
  58. Crystal structure of 2-chloro-3-(isopentylamino)naphthalene-1,4-dione, C 15 H 16 ClNO 2
  59. The crystal structure of bis(2-acetyl-5-methoxyphenyl)carbonate 1.5 hydrate, C19H18O7
  60. The crystal structure of poly[(μ 4-4,4′-(azanediylbis(methylene))dibenzoato-κ 4 O:N:O′:Oʺ)zinc(II)], C16H13NO4Zn
  61. The crystal structure of catena-poly[(1,10-phenanthroline-k2N,N′)-(μ3-tetraoxidomoybdato(VI)-k3O:O′:O″)manganese(II)] C12H8N2O4MoMn
  62. Crystal structure of catena-poly[(4-hydroxyl-5-(methoylcarbonyl)thiophene-2-carboxylato-κ1 O)-(μ2-piperazine-1,4-diylbis(pyridin-4-ylmethanone)-κ2 N:N′)silver(I)] monohydrate, C23H23AgN4O8S
  63. Crystal structure of bis(4-bromo-2-(((3-bromopropyl)imino)methyl)phenolato-κ2N,O)-oxido-vanadium(IV), C20H20Br4N2O3V
  64. The crystal structure of (2a′S,2a1′S,3R,5a′S,7′R)-5-(furan-3-yl)-2a′,2a1′-dihydroxy-7′-methyldecahydro-2H-spiro[furan-3,6′-naphtho[1,8-bc]furan]-2,2′(2a′H)-dione, C19H22O7
  65. The crystal structure of 3-bromopicolinic acid, C6H4BrNO2
  66. Crystal structure of 1,1′-(1,4-phenylenebis(methylene))bis(pyridin-1-ium) bis(1,2-dicyanoethene-1,2-dithiolato-κ2 S,S) platinum(II), C26H18N6PtS4
  67. Synthesis and crystal structure of 5-(8-((3-carboxyazetidin-1-ium-1-yl)methyl)-7-hydroxy-4-oxo-4H-chromen-3-yl)-2-hydroxybenzenesulfonate monohydrate, C20H19NO10S
  68. The crystal structure of 3-amino-5-carboxypyridin-1-ium bromide, C6H7BrN2O2
  69. The crystal structure of (2-hydroxy-5-methyl-phenyl)-(1H-pyrazol-4-yl)-methanone hemihydrate, C11H10.5N2O2.5
  70. Crystal structure of tetraaqua-(2-(4-formylphenoxy)acetato-k1O)cadmium(II), C18H22O12Cd
  71. Crystal structure of diethyl 6,12-dimethyl-3,9-di-p-tolyl-3,9-diazapentacyclo[6.4.0.02,7.04,11.05,10]dodecane-1,5-dicarboxylate, C32H38N2O4
  72. Crystal structure of (E)-N′-(1-(3-chloro-4-fluorophenyl)ethylidene)-4-hydroxy – tetrahydrofuran (2/1), C17H16ClFN2O2.5
https://doi.org/10.1515/ncrs-2021-0300
Creative Commons
BY 4.0

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Redetermination of the crystal structure of 3-bromonitrobenzene at 200 K, C6H4BrNO2 – temperature effects on cell constants
  4. Crystal structure of (E)-ethyl 2-((4-oxo-4H-chromen-3-yl)methyleneaminooxy)acetate, C14H13NO5
  5. Crystal structure of (8R,10R,14R, Z)-2-((3–Fluoropyridin-4-yl) methylene)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((R)-2,6, 6-trimethyltetrahydro-2H-pyran-2-yl) hexadecahydro-3H-cyclopenta[a] phenanthren-3-one, C36H52FNO3
  6. Crystal structure of [6,6′-((1E,1′E)-(propane-1,3- diylbis(azaneylylidene))bis(methaneylylidene)) bis(3-chlorophenol)-κ4N,N′,O,O′] copper(II), C17H14Cl2CuN2O2
  7. The crystal structure of 6-amino-2-carboxypyridin-1-ium bromide, C6H7BrN2O2
  8. Redetermination of the crystal structure of bis[N,N′-ethylenebis(acetylacetoniminato)nickel(II)] sodium perchlorate, C24H36ClN4NaNi2O8
  9. The crystal structure of 3-methyl-2,6-dinitrophenol, C7H6N2O5
  10. The crystal structure of 5-chloro-2-(quinolin-8-yl)isoindoline-1,3-dione, C17H9ClN2O2
  11. Crystal structure of trans-tetraaqua-bis{2-carboxy-4-((5-carboxypyridin-3-yl)oxy)benzoato-κ1 N}cobalt(II) dihydrate C28H28O20N2Co
  12. Crystal structure of 3-allyl-4-(2-bromoethyl)-5-(4-methoxyphenyl)-2-(p-tolyl)furan, C23H23BrO2
  13. The crystal structure of 6,6′-(((2-(dimethylamino)ethyl)azanediyl)bis(methylene))bis(benzo[d][1,3]dioxol-5-ol ato-κ4N,N′,O,O′)-(pyridine-2,6-dicarboxylato-N,O,O′)-titanium(IV)-dichloromethane(1/1), C27H25N3O10Ti
  14. Crystal structure of (((1E,1′E)-1,2-phenylenebis(methaneylylidene))bis(hydrazin-1-yl-2-ylidene))bis(aminomethaniminium) dinitrate C10H16N10O6
  15. Crystal structure of catena-poly[triaqua-(μ 2-1,3-di(1H-imidazol-1-yl)propane-κ 2 N:N′)-(4,4′-(1H-1,2,4-triazole-3,5-diyl)dibenzoato-κ 1 O)nickel(II)]N,N′-dimethylformamide (1/1), C28H35N8O8Ni
  16. The crystal structure of 3,3′-[1,4-phenylenebis(methylene)]bis(1-ethenyl-1H-imidazol-3-ium) dichloride – dichloromethane – water (1/1/1), C19H24Cl4N4O1
  17. Crystal structure of 1,1′-(methane-1,1-diyl)bis(3-propyl-1H-imidazol-3-ium) bis(hexafluoridophosphate), C13H22F12N4P2
  18. Crystal structure of dichlorido-bis(4-chlorophenyl-κC 1)tin(IV), C12H8Cl4Sn
  19. Synthesis and crystal structure of 4-acetylpyrene, C18H12O
  20. Crystal structure of 2,2′-(butane-1,4-diylbis(azanylylidene))bis(methanylylidene))bis(4-methoxyphenol), C20H24N2O4
  21. The crystal structure of (E)-2-(((5-((triphenylstannyl)thio)-1,3,4-thiadiazol-2-yl)imino)methyl)phenol, C27H21N3OS2Sn
  22. Crystal structure of diaqua-bis(μ2-6-phenylpyridine-2-carboxylate-κ3N,O:O)-bis(6-phenylpyridine-2-carboxylato-κ2N,O)lead(II) – N,N-dimethylformamide – water (1/2/4), C54H58N6O16Pb2
  23. Crystal structure of methyl 4-acetoxy-3-methoxybenzoate, C11H12O5
  24. Crystal structure of 2,2′-(propane-1,3-dilylbis(azaneylylidene))bis(methanylylidene)bis(4-methylphenol), C19H22N2O2
  25. Crystal structure of dichlorido-bis(4-methylphenyl-κC1)tin(IV), C14H14Cl2Sn
  26. Crystal structure of methyl (E)-3-(4-acetoxyphenyl)acrylate, C12H12O4
  27. The crystal structure of bis(benzoato-κ2 O,O′)-(2,9-dimethyl-1,10-phenanthroline-κ2 N,N′)-copper(II), C28H22CuN2O4
  28. Crystal structure of (8R,10R,14R,Z)-12-hydroxy-2-((6-methoxypyridin-2-yl)methylene)-4,4,8,10,14-pentamethyl-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)hexadecahydro-3H-cyclopenta[a]phenanthren-3-one–water (2/1), C37H56NO4.5
  29. Crystal structure of dimethyl-bis(4-bromophenyl-κC1)tin(IV), C14H14Br2Sn
  30. The crystal structure of the cocrystal di-μ2-chlorido-octamethyl-di-μ3-oxido-bis(2,3,4,5-tetrafluorobenzoato-κ2 O,O′)tetratin(IV) ─ octamethyl-di-μ3-oxido-bis(μ2-2,3,4,5-tetrafluorobenzoato-κ2 O:O′)-bis(μ2-2,3,4,5-tetrafluorobenzoato-κ2 O:O;O′)tetratin(IV) C58H54Cl2F24O16Sn8
  31. Crystal structure of 3-iodo-N 2-(2-methyl-1-(methylsulfonyl)propan-2-yl)-N 1-(2-methyl-4-(perfluoropropan-2-yl)phenyl)phthalamide, C23H22F7I1N2O4S1
  32. Crystal structure of 1-(2-(4-bromophenyl)-2,3-dihydro-1H-benzo[e]indol-1-yl)-naphthalen-2-ol – dichloromethane – dimethyl sulfoxide (1/1/1), C28H18BrNO·CH2Cl2·C2H6SO
  33. Crystal structure of [meso-5,7,7,12,14,14,-hexamethyl-1,4,8,11-tetraazacyclotetradecane]nickel(II) diperchlorate – dimethylsulphoxide (1/2), C20H48Cl2N4NiO10S2
  34. Crystal structure of 1,1′-(1,3-phenylenebis(methylene))bis(pyridin-1-ium) bis(1,2-dicyanoethene-1,2-dithiolato-κ2 S:S) palladium(II), C26H18N6PdS4
  35. The crystal structure of bis(6-phenylpyridine-2-carboxylato-κ2 N,O)copper(II), C24H16N2O4Cu
  36. Crystal structure of dichlorido-bis(4-chlorophenyl-κC)-bis(triphenylarsine oxide-κO)tin(IV), C48H38As2Cl4O2Sn
  37. Crystal structure of (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane-κ 8 N 2, O 6) potassium cyclopentadienide, [K([2.2.2]crypt)]Cp, C23H41KN2O6
  38. The crystal structure of bis(2-oxidopyridin-1-ium-3-carboxylato-κ2O,O′)-(phenantroline-κ2N,N′)manganese(II) - methanol (1/3), C27H28N4O9Mn
  39. Crystal structure of 4-(dimethylamino)pyridinium dibromido-tris(4-chlorophenyl-κC)stannate(IV), C25H23Br2Cl3N2Sn
  40. Crystal structure of (3E,5E)-1-(4-cyanobenzenesulfonyl)-3,5-bis(3-fluorobenzylidene)piperidin-4-one-dichloromethane (1/1), C27H20Cl2F2N2O3S
  41. Crystal structure of (3E,5E)-3,5-bis(4-fluorobenzylidene)-1-((4-trifluoromethyl)benzenesulfonyl)piperidin-4-one, C26H18F5NO3S
  42. Crystal structure of chlorido-(4-methyl-2-((phenylimino)methyl)phenolato-κ2 N,O)-(pyridine-κ1 N)platinum(II), C19H17ClN2OPt
  43. Crystal structure of (4-methylbenzyl)(triphenyl)phosphonium chloride dihydrate, C26H28ClO2P
  44. The crystal structure of poly[μ2-chlorido-(μ2-1,2-bis(4-pyridyl)ethane-κ2N:N′silver(I)], C12H12AgClN2
  45. Crystal structure of poly[(μ4-benzene-1,2,4,5-tetracarboxylato)-bis(μ2-adipohydrazide)dicadmium], C11H15N4O6Cd
  46. The crystal structure of (E)-N′-(butan-2-ylidene)isonicotinohydrazide 0.5 hydrate C10H13N3O·0.5H2O
  47. The crystal structure of bis(6-phenylpyridine-2-carboxylate-κ2 N,O)-(2,2′-bipyridine-κ2 N,N′)zinc(II) monohydrate, C34H26N4O5Zn
  48. The crystal structure of (1R *,2S *)-1,2-bis(2-fluorophenyl)-3,8-dimethoxyacenaphthene-1,2-diol, C26H20F2O4
  49. Crystal structure of catena-poly[(μ2-1-((2-ethyl-4-methyl-1H-imidazol-1-yl)methyl)-1H-benzotriazole-κ2N:N′)-(nitrato-κ2O,O′)silver (I)], C13H15Ag1N6O3
  50. The crystal structure of [(phenantroline-κ2 N,N′)-bis(6-phenylpyridine-2-carboxylate-κ2 N,O)cobalt(II)]monohydrate, C36H26N4O5Co
  51. Crystal structure of (1E)-N′-[(1E)-1-(4-chlorophenyl)ethylidene]-2-[1-(4-chlorophenyl)ethylidene]hydrazine-1-carbohydrazonamide, C 17 H 17 Cl 2 N 5
  52. The crystal structure of (E)-2-((tert-butylimino)methyl)-4-chlorophenol, C11H14ClNO
  53. Crystal structure of all-cis-2,4,6-trihydroxycyclohexane- 1,3,5-triaminium chloride sulfate, C6H18ClN3O7S
  54. Crystal structure of dichlorido-bis(dimethyl sulfoxide-κO)bis(4-methylphenyl-κC 1)tin(IV), C18H26Cl2O2S2Sn
  55. Crystal structure of dichlorido-bis(4-chlorophenyl-κC 1)(2,2′-bipyridyl-κ 2 N,N′)tin(IV), C22H16Cl4N2Sn
  56. Redetermination of the crystal structure of (E)-5-bromo-2-hydroxybenzaldehyde oxime, C 7 H 6 BrNO 2
  57. The crystal structure of (E)-amino(2-(4-methylbenzylidene)hydrazineyl)methaniminium 4-methylbenzoate, C9H13N4 + C8H7O2 −
  58. Crystal structure of 2-chloro-3-(isopentylamino)naphthalene-1,4-dione, C 15 H 16 ClNO 2
  59. The crystal structure of bis(2-acetyl-5-methoxyphenyl)carbonate 1.5 hydrate, C19H18O7
  60. The crystal structure of poly[(μ 4-4,4′-(azanediylbis(methylene))dibenzoato-κ 4 O:N:O′:Oʺ)zinc(II)], C16H13NO4Zn
  61. The crystal structure of catena-poly[(1,10-phenanthroline-k2N,N′)-(μ3-tetraoxidomoybdato(VI)-k3O:O′:O″)manganese(II)] C12H8N2O4MoMn
  62. Crystal structure of catena-poly[(4-hydroxyl-5-(methoylcarbonyl)thiophene-2-carboxylato-κ1 O)-(μ2-piperazine-1,4-diylbis(pyridin-4-ylmethanone)-κ2 N:N′)silver(I)] monohydrate, C23H23AgN4O8S
  63. Crystal structure of bis(4-bromo-2-(((3-bromopropyl)imino)methyl)phenolato-κ2N,O)-oxido-vanadium(IV), C20H20Br4N2O3V
  64. The crystal structure of (2a′S,2a1′S,3R,5a′S,7′R)-5-(furan-3-yl)-2a′,2a1′-dihydroxy-7′-methyldecahydro-2H-spiro[furan-3,6′-naphtho[1,8-bc]furan]-2,2′(2a′H)-dione, C19H22O7
  65. The crystal structure of 3-bromopicolinic acid, C6H4BrNO2
  66. Crystal structure of 1,1′-(1,4-phenylenebis(methylene))bis(pyridin-1-ium) bis(1,2-dicyanoethene-1,2-dithiolato-κ2 S,S) platinum(II), C26H18N6PtS4
  67. Synthesis and crystal structure of 5-(8-((3-carboxyazetidin-1-ium-1-yl)methyl)-7-hydroxy-4-oxo-4H-chromen-3-yl)-2-hydroxybenzenesulfonate monohydrate, C20H19NO10S
  68. The crystal structure of 3-amino-5-carboxypyridin-1-ium bromide, C6H7BrN2O2
  69. The crystal structure of (2-hydroxy-5-methyl-phenyl)-(1H-pyrazol-4-yl)-methanone hemihydrate, C11H10.5N2O2.5
  70. Crystal structure of tetraaqua-(2-(4-formylphenoxy)acetato-k1O)cadmium(II), C18H22O12Cd
  71. Crystal structure of diethyl 6,12-dimethyl-3,9-di-p-tolyl-3,9-diazapentacyclo[6.4.0.02,7.04,11.05,10]dodecane-1,5-dicarboxylate, C32H38N2O4
  72. Crystal structure of (E)-N′-(1-(3-chloro-4-fluorophenyl)ethylidene)-4-hydroxy – tetrahydrofuran (2/1), C17H16ClFN2O2.5
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 16.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2021-0300/html
Button zum nach oben scrollen